Moclobemide: Clinical Trials

5 trials of Moclobemide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 not yet recruiting. 2 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 32Completed 1, Terminated 1
Phase 41Not yet recruiting 1

Follow Moclobemide: new trials by email Literature Review of Moclobemide trials Research Report on Moclobemide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Hydroxyzine for Patients With Panic Disorder
Hydroxyzine, Escitalopram Oxalate - Panic Disorder
Phase 4Not yet recruitingSultan Qaboos University802023-12-302023-02-21
Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
escitalopram, Moclobemide, Placebo - Cap - Addiction
Phase 2TerminatedChina Medical University Hospital902016-01-142019-07-24
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Nicotine Patch, Moclobemide - Nicotine Dependence
Phase 2CompletedJed E. Rose762013-09-012017-08-23
Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Amisulpride, Moclobemide - Clozapine-induced Hypersalivation
Phase 3CompletedBeersheva Mental Health Center542008-11-012012-07-26

Conditions studied

Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Dementia (1)  ·  Depression (1)  ·  Panic Disorder (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Smoking Cessation (1)  ·  Tobacco Use Disorder (1)

Sponsors

Beersheva Mental Health Center (1)  ·  China Medical University Hospital (1)  ·  Hannover Medical School (1)  ·  Jed E. Rose (1)  ·  Sultan Qaboos University (1)

Countries

Germany (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Alexander Grinshpoon, MD (1)  ·  Anatoly Kreinin, MD, PhD (1)  ·  Chanoch Miodownik, MD (1)  ·  Diana Shestakova, MD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Igor Libov (1)  ·  Jed E Rose, Ph.D. (1)  ·  Ko Ying-Chin, PHD (1)  ·  Vladimir Lerner, MD, PhD (1)

Results publications

PMID 20964499

NIH funding

P50DA027840 (1)